NIGER, MONICA

NIGER, MONICA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 19 di 19 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model 2022 Azzollini, JacopoVingiani, AndreaAgnelli, LucaRosina, EricaDucceschi, MonikaNiger, MonicaDamian, Silviade Braud, FilippoPruneri, Giancarlo + Article (author) -
MGMT inactivation as a new biomarker in patients with advanced biliary tract cancers 2022 Niger, MonicaNichetti, FedericoPircher, ChiaraVingiani, AndreaAgnelli, LucaPusceddu, SaraCorti, FrancescaPrisciandaro, MicheleBini, MartaPruneri, GiancarloMazzaferro, VincenzoPietrantonio, Filippode Braud, Filippo + Article (author) -
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index 2021 Brandi G.Niger M.Caputo F.Casagrande M.Nichetti F.de Braud F. + Article (author) -
FOLFOXIRI-Bevacizumab or FOLFOX-Panitumumab in Patients with Left-Sided RAS/BRAF Wild-Type Metastatic Colorectal Cancer: A Propensity Score-Based Analysis 2021 Pietrantonio F.Niger M.de Braud F. + Article (author) -
Maintenance Therapy with Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients with RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial 2019 Pietrantonio, FilippoRaimondi, AlessandraSartore-Bianchi, AndreaNiger, MonicaPetrelli, FaustoLongarini, RaffaellaDi Bartolomeo, Mariade Braud, Filippo + Article (author) -
Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives 2019 Corti, FrancescaNichetti, FedericoRaimondi, AlessandraNiger, MonicaPruneri, Giancarlode Braud, FilippoPusceddu, Sara + Article (author) -
Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial 2019 Niger, Monicade Braud, FilippoPietrantonio, Filippo + Article (author) -
Prognostic impact of ATM mutations in patients with metastatic colorectal cancer 2019 Randon, GiovanniFucà, GiovanniRaimondi, AlessandraPagani, FilippoPeverelli, GiorgiaNiger, MonicaPruneri, Giancarlode Braud, FilippoPietrantonio, Filippo + Article (author) -
Comparative Effectiveness of Gemcitabine plus Nab-Paclitaxel and FOLFIRINOX in the First-Line Setting of Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis 2019 Pusceddu, SaraGhidini, MicheleCorti, FrancescaNiger, MonicaNichetti, FedericoCabiddu, Maryde Braud, FilippoPetrelli, Fausto + Article (author) -
Metronomic Capecitabine With Cyclophosphamide Regimen in Unresectable or Relapsed Pseudomyxoma Peritonei 2019 Raimondi, AlessandraNiger, MonicaRandon, GiovanniDe Braud, FilippoPietrantonio, Filippo + Article (author) -
Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer : Real-World Data from the RAMoss Study 2018 M. NigerF. Pietrantonio + Article (author) -
Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer 2017 Vernieri, ClaudioVolpi, Chiara CostanzaNiger, MonicaValtorta, EmanueleFucà, GiovanniDi Bartolomeo, MariaDe Braud, FilippoPietrantonio, Filippo + Article (author) -
Preoperative Capecitabine, Oxaliplatin, and Irinotecan in Resectable Gastric or Gastroesophageal Junction Cancer: Pathological Response as Primary Endpoint and FDG-PET Predictions 2017 Pietrantonio, FilippoCotsoglou, ChristianInfante, GabrieleCoppa, JorgelinaPadovano, BarbaraMennitto, AlessiaNiger, MonicaFucà, GiovanniLazzati, SilviaGreco, GiorgioDelconte, GabrieleDe Braud, FilippoMazzaferro, VincenzoDi Bartolomeo, Maria + Article (author) -
Safety of long-term exposure to abiraterone acetate in patients with castration-resistant prostate cancer and concomitant cardiovascular risk factors 2016 E. VerzoniM. NigerF. De BraudR. Valdagni + Article (author) -
Progress in treatments for colorectal cancer peritoneal metastases during the years 2010-2015 : a systematic review 2016 F. PietrantonioM. Niger + Article (author) -
GNAS mutations as prognostic biomarker in patients with relapsed peritoneal pseudomyxoma receiving metronomic capecitabine and bevacizumab : A clinical and translational study 2016 F. PietrantonioC. MaggiM. NigerA. MennittoF. de Braud + Article (author) -
A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer 2015 F. PietrantonioP. BiondaniNIGER, MONICAGHIDINI, MICHELEBOZZARELLI, SILVIAF. De Braud + Article (author) -
Undetected toxicity risk in pharmacogenetic testing for dihydropyrimidine dehydrogenase 2015 F.S. FalvellaS. CheliC. MaggiM. NigerF. RicchiniI. BossiF. de BraudE. ClementiF. Pietrantonio + Article (author) -
BRAF in metastatic colorectal cancer : the future starts now 2015 M. NigerI. BossiF. De BraudF. Pietrantonio + Article (author) -